PulseAugur
EN
LIVE 23:54:50

AI/ML studies surge in high-income countries, focus on neoplasms

By PulseAugur Editorial · [1 sources] ·

A recent analysis of AI/ML studies conducted between 2010 and 2023 reveals a significant growth trend, particularly in high-income nations. Out of 3,106 studies examined, a notable portion were FDA-regulated (7.6%) and hospital-sponsored (44.2%). The research also indicated that 12.9% of these studies focused on neoplasms, with enrollment numbers reaching up to 13,977,257 participants. AI

IMPACT Analysis shows a growth in AI/ML studies, with a focus on specific medical areas and regulatory oversight.

RANK_REASON The cluster reports on a study analyzing trends in AI/ML research, which falls under the research category. [lever_c_demoted from research: ic=1 ai=0.7]

Read on Mastodon — mastodon.social →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI/ML studies surge in high-income countries, focus on neoplasms

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster reports on a study analyzing trends in AI/ML research, which falls under the research category. [lever_c_demoted from research: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
138 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Mastodon — mastodon.social TIER_1 English(EN) · suwebreza ·

    AI/ML studies show rapid growth in high-income countries 2010-2023. 📈 3106 studies, with 7.6% FDA-regulated 🏥 44.2% hospital-sponsored 🧠 12.9% target neoplasms

    AI/ML studies show rapid growth in high-income countries 2010-2023. 📈 3106 studies, with 7.6% FDA-regulated 🏥 44.2% hospital-sponsored 🧠 12.9% target neoplasms 📊 Enrollment skewed, max 13,977,257 # AI # ML # ClinicalTrials # Healthcare # Research # Pub2Post https://dev. https:// …

    LINKS tnyp.me/…/m

RELATED ENTITIES

RELATED TOPICS